Showing results (41-50 of 254) with videos related to
Sort By:
Pageof 26
JNCI Cancer Spectrum|October 23, 2024
Trends in age and prostate-specific antigen at prostate cancer diagnosis between 2010 and 2019Lukas Owens, Ojas Brahme, Roman Gulati, et al.Journal of the National Cancer Institute|May 20, 2016
Evaluating Markers for Guiding TreatmentStuart G Baker, Marco BonettiEpidemiology (Cambridge, Mass.)|July 3, 2004
Case-control studies of the efficacy of cancer screening: overcoming bias from nonrandom patterns of screeningNoel S Weiss, Preet K Dhillon, Ruth EtzioniJournal of the National Cancer Institute. Monographs|August 22, 2013
Evaluation of new technologies for cancer control based on population trends in disease incidence and mortalityRuth Etzioni, Isabelle Durand-Zaleski, Iris Lansdorp-VogelaarJNCI Cancer Spectrum|October 23, 2025
Age-Specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstructionMohamed Albirair, Yaw Nyame, Roman Gulati, et al.Cancer|June 16, 2018
Beyond classic risk adjustment: Socioeconomic status and hospital performance in urologic oncology surgeryAnobel Y Odisho, Ruth Etzioni, John L GorePatterns (New York, N.Y.)|August 18, 2021
Accounting for uncertainty during a pandemicJon Zelner, Julien Riou, Ruth Etzioni, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 6, 2008
Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approachRuth Etzioni, Roman Gulati, Seth Falcon, et al.Cancer|January 26, 2018
Racial disparities in prostate cancer survival in a screened population: Reality versus artifactDhamanpreet Kaur, Ernesto Ulloa-Pérez, Roman Gulati, et al.Biomarker Insights|August 22, 2020
Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer ScreeningStuart G Baker, Barnett S KramerPageof 26